Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells.

Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 12/2002; 99(24):15451-5. DOI: 10.1073/pnas.202604299
Source: PubMed

ABSTRACT The adult mouse intestine contains an intricate vascular network. The factors that control development of this network are poorly understood. Quantitative three-dimensional imaging studies revealed that a plexus of branched interconnected vessels developed in small intestinal villi during the period of postnatal development that coincides with assembly of a complex society of indigenous gut microorganisms (microbiota). To investigate the impact of this environmental transition on vascular development, we compared the capillary networks of germ-free mice with those of ex-germ-free animals colonized during or after completion of postnatal gut development. Adult germ-free mice had arrested capillary network formation. The developmental program can be restarted and completed within 10 days after colonization with a complete microbiota harvested from conventionally raised mice, or with Bacteroides thetaiotaomicron, a prominent inhabitant of the normal mouse/human gut. Paneth cells in the intestinal epithelium secrete antibacterial peptides that affect luminal microbial ecology. Comparisons of germ-free and B. thetaiotaomicron-colonized transgenic mice lacking Paneth cells established that microbial regulation of angiogenesis depends on this lineage. These findings reveal a previously unappreciated mechanism of postnatal animal development, where microbes colonizing a mucosal surface are assigned responsibility for regulating elaboration of the underlying microvasculature by signaling through a bacteria-sensing epithelial cell.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The human intestinal microbiota is our main bacterial reservoir with 1013–1014 cells. It is divided into a permanent (or resident) microbiota, which provides several benefits to its host, and a variable microbiota, made of exogenous bacteria that cannot sustainably settle because of the ‘barrier effect’ exerted by anaerobic bacteria. The intestinal microbiota is besides a major reservoir for antibiotic-resistant bacteria, which can be enriched by acquired multidrug-resistant bacteria such as enterobacteria that produce extended-spectrum beta-lactamases (ESBL) or carbapenemases. Antibiotics play a key role in this phenomenon in decreasing the species diversity within the intestinal microbiota while promoting the growth of resistant bacteria. In this review, we will see how the intestinal microbiota stands at the very heart of bacterial multidrug-resistance. We will tackle the different phases of the colonization by resistant bacteria and their underlying determinants, particularly the role played by antibiotics and the influence of the intestinal densities of multidrug-resistant bacteria on infections and patient-to-patient transmission. Eventually, we will review the current perspectives and those to come to combat the intestinal colonization by multidrug-resistant bacteria.
    12/2013; DOI:10.1016/j.antinf.2013.08.002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The intestinal microbiota is a complex environment that hosts 10(13) to 10(14) bacteria. Among these bacteria stand multidrug-resistant enterobacteria (MDRE), which intestinal densities can substantially vary, especially according to antibiotic exposure. The intestinal density of MDRE and their relative abundance (i.e., the proportion between the density of MDRE and the density of total enterobacteria) could play a major role in the infection process or patient-to-patient transmission. This review discusses the recent advances in understanding (i) what causes variations in the density or relative abundance of intestinal colonization, (ii) what are the clinical consequences of these variations, and (iii) what are the perspectives for maintaining these markers at low levels.
    Frontiers in Microbiology 05/2013; 4:129. DOI:10.3389/fmicb.2013.00129 · 3.94 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Brain and the gastrointestinal (GI) tract are intimately connected to form a bidirectional neurohumoral communication system. The communication between gut and brain, knows as the gut-brain axis, is so well established that the functional status of gut is always related to the condition of brain. The researches on the gut-brain axis were traditionally focused on the psychological status affecting the function of the GI tract. However, recent evidences showed that gut microbiota communicates with the brain via the gut-brain axis to modulate brain development and behavioral phenotypes. These recent findings on the new role of gut microbiota in the gut-brain axis implicate that gut microbiota could associate with brain functions as well as neurological diseases via the gut-brain axis. To elucidate the role of gut microbiota in the gut-brain axis, precise identification of the composition of microbes constituting gut microbiota is an essential step. However, identification of microbes constituting gut microbiota has been the main technological challenge currently due to massive amount of intestinal microbes and the difficulties in culture of gut microbes. Current methods for identification of microbes constituting gut microbiota are dependent on omics analysis methods by using advanced high tech equipment. Here, we review the association of gut microbiota with the gut-brain axis, including the pros and cons of the current high throughput methods for identification of microbes constituting gut microbiota to elucidate the role of gut microbiota in the gut-brain axis.
    Protein & Cell 05/2013; DOI:10.1007/s13238-013-3017-x · 2.85 Impact Factor


Available from